Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2003
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group.
Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F, Driessen C, Rudiger T, Muller-Hermelink K, Diehl V, Engert A; German Hodgkin Lymphoma Study Group (GHSG). Rehwald U, et al. Blood. 2003 Jan 15;101(2):420-4. doi: 10.1182/blood.V101.2.420. Blood. 2003. PMID: 12509381 Free article. Clinical Trial.